The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


YTRACIS

1.850 GBq/ml Infus/Pdr/Oral Soln

CIS bio InternationalEU/1/03/250/001

Main Information

Trade NameYTRACIS
Active SubstancesYTTRIUM (90 Y)
Strength1.850 GBq/ml
Dosage FormInfus/Pdr/Oral Soln
Licence HolderCIS bio International
Licence NumberEU/1/03/250/001

Group Information

ATC CodeV10AA02 yttrium (90Y) ferrihydroxide colloid

Status

Authorised/WithdrawnAuthorised
Licence Issued24/03/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back